1. Home
  2. ISRL vs MYO Comparison

ISRL vs MYO Comparison

Compare ISRL & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISRL
  • MYO
  • Stock Information
  • Founded
  • ISRL 2021
  • MYO 2004
  • Country
  • ISRL United States
  • MYO United States
  • Employees
  • ISRL N/A
  • MYO N/A
  • Industry
  • ISRL Blank Checks
  • MYO Industrial Specialties
  • Sector
  • ISRL Finance
  • MYO Health Care
  • Exchange
  • ISRL Nasdaq
  • MYO Nasdaq
  • Market Cap
  • ISRL 143.1M
  • MYO 121.5M
  • IPO Year
  • ISRL 2023
  • MYO 2017
  • Fundamental
  • Price
  • ISRL $11.23
  • MYO $3.81
  • Analyst Decision
  • ISRL
  • MYO Strong Buy
  • Analyst Count
  • ISRL 0
  • MYO 4
  • Target Price
  • ISRL N/A
  • MYO $7.63
  • AVG Volume (30 Days)
  • ISRL 44.1K
  • MYO 107.4K
  • Earning Date
  • ISRL 01-01-0001
  • MYO 11-05-2024
  • Dividend Yield
  • ISRL N/A
  • MYO N/A
  • EPS Growth
  • ISRL 33.17
  • MYO N/A
  • EPS
  • ISRL 0.29
  • MYO N/A
  • Revenue
  • ISRL N/A
  • MYO $21,111,062.00
  • Revenue This Year
  • ISRL N/A
  • MYO $53.19
  • Revenue Next Year
  • ISRL N/A
  • MYO $39.01
  • P/E Ratio
  • ISRL $38.48
  • MYO N/A
  • Revenue Growth
  • ISRL N/A
  • MYO 21.22
  • 52 Week Low
  • ISRL $10.57
  • MYO $1.06
  • 52 Week High
  • ISRL $11.24
  • MYO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ISRL 65.14
  • MYO 46.02
  • Support Level
  • ISRL $11.14
  • MYO $3.74
  • Resistance Level
  • ISRL $11.23
  • MYO $4.05
  • Average True Range (ATR)
  • ISRL 0.02
  • MYO 0.18
  • MACD
  • ISRL -0.00
  • MYO 0.00
  • Stochastic Oscillator
  • ISRL 100.00
  • MYO 22.12

About ISRL Israel Acquisitions Corp

Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: